These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6516100)

  • 1. [Results of vitrectomy in the pre-proliferative and early proliferative stages of diabetic retinopathy].
    Fedorov SN; Glinchuk IaI; Barabash NS
    Vestn Oftalmol; 1984; (6):20-3. PubMed ID: 6516100
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravitreal long-acting gas in the prevention of early postoperative vitreous hemorrhage in diabetic vitrectomy.
    Yang CM; Yeh PT; Yang CH
    Ophthalmology; 2007 Apr; 114(4):710-5. PubMed ID: 17275908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ocular complications in diabetes: towards standardizing screening and care].
    Massin P
    Rev Prat; 2001 Oct; 51(16):1776-82. PubMed ID: 11795121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Timing of vitrectomy for proliferative diabetic retinopathy in cases with type II diabetes mellitus].
    Li X; Jiang Y; Ye C; Li C
    Zhonghua Yan Ke Za Zhi; 1999 Mar; 35(2):116-8. PubMed ID: 11835788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term results of photocoagulation in proliferative diabetic retinopathy].
    Gerke E; Reuber A
    Fortschr Ophthalmol; 1988; 85(5):517-8. PubMed ID: 3224924
    [No Abstract]   [Full Text] [Related]  

  • 6. Visual prognosis after panretinal photocoagulation for proliferative diabetic retinopathy.
    Bek T; Erlandsen M
    Acta Ophthalmol Scand; 2006 Feb; 84(1):16-20. PubMed ID: 16445434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [On the role of the posterior hyaloid membrane in the pathogenesis of and surgery for proliferative diabetic retinopathy].
    Sdobnikova SV; Stoliarenko GE; Fedorov AA; Marchenko NR
    Vestn Oftalmol; 1996; 112(4):5-7. PubMed ID: 9019911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study of the role of cytokines in various eye diseases. 2. Diabetic retinopathy].
    Slepova OS; Gerasimenko VL; Zakharova GIu; Novikova-Bilak TI
    Vestn Oftalmol; 2001; 117(3):35-7. PubMed ID: 11521435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive clinical features and outcomes of vitrectomy for proliferative diabetic retinopathy.
    Yorston D; Wickham L; Benson S; Bunce C; Sheard R; Charteris D
    Br J Ophthalmol; 2008 Mar; 92(3):365-8. PubMed ID: 18303158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of closed vitrectomy on eye function and the course of proliferative diabetic retinopathy].
    Fedorov SN; Makhacheva ZA; Glinchuk IaI; Mironova EM
    Vestn Oftalmol; 1985; 101(4):29-33. PubMed ID: 4060408
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anterior fibrovascular proliferation. A rare complication of vitrectomy for proliferative diabetic retinopathy].
    Le Mer Y; Des Beauvais T; Raynaud JF; Ribeaudeau F
    J Fr Ophtalmol; 1996; 19(5):369-73. PubMed ID: 8762905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Can vitrectomy without use of microscissors improve results of surgery for proliferative diabetic retinopathy?].
    Gribomont AC
    Bull Soc Belge Ophtalmol; 2002; (283):61-5. PubMed ID: 12058489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of intraocular tamponade in treatment of complications of proliferative diabetic retinopathy].
    Nawrocki J; Dziegielewski K; Pikulski Z
    Klin Oczna; 1993; 95(9-10):354-6. PubMed ID: 8022167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of eye disease in the insulin-dependent diabetic patient.
    Klein R
    Prim Care; 1983 Dec; 10(4):677-90. PubMed ID: 6562666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The equation: a photo essay acquainting the diabetic patient with the goals of pars plana vitrectomy for proliferative diabetic retinopathy.
    Goldberg RE; Callen DS; Creedon MS
    J Ophthalmic Nurs Technol; 1987; 6(3):95. PubMed ID: 3648152
    [No Abstract]   [Full Text] [Related]  

  • 16. The visual outcome of vitrectomy for advanced diabetic retinopathy.
    Fulcher T; Acheson RW
    Ir Med J; 1995; 88(1):26-7. PubMed ID: 7737838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of diabetic retinopathy.
    Saxena S; Jalali S; Meredith TA; Holekamp NM; Kumar D
    Indian J Ophthalmol; 2000 Dec; 48(4):321-30. PubMed ID: 11340894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitrectomy with peeling of the inner limiting membrane for treating diabetic macular edema.
    Kolacny D; Parys-Vanginderdeuren R; Van Lommel A; Stalmans P
    Bull Soc Belge Ophtalmol; 2005; (296):15-23. PubMed ID: 16050416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Should associated intraoperative and/or postoperative photocoagulation be systematic during or after vitrectomy for proliferative diabetic vitreoretinopathy?].
    Hajji Z; Rouillot JS; Roth P; Grange JD
    J Fr Ophtalmol; 2003 Jan; 26(1):47-53. PubMed ID: 12610409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmin-assisted vitrectomy for management of proliferative membrane in proliferative diabetic retinopathy: a pilot study.
    Hirata A; Takano A; Inomata Y; Yonemura N; Sagara N; Tanihara H
    Retina; 2007 Oct; 27(8):1074-8. PubMed ID: 18040248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.